On Thursday, Workiva Cl A hit an important technical milestone, with its Relative Strength (RS) Rating climbing into the 80-plus percentile with an upgrade to 82, a rise from 79 the day before.
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the top-performing stocks tend to have an RS Rating of at least 80 as they launch their biggest runs.
Hone Your Stock-Picking Skills By Focusing On These Factors
Workiva Cl A is not currently showing a potential entry point. See if the stock goes on to build a sound pattern that could ignite a new run.
While earnings growth declined in the company's most recent quarterly report from 700% to 0%, revenue rose 17%, up from 15% in the prior report.
The company holds the No. 4 rank among its peers in the Computer Software-Database industry group. Confluent is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
